Using variation between countries to estimate demand for Cochrane reviews when access is free: a cost-benefit analysis.

We estimate that free access would cost less than US$2 per additional download for 20 of the 28 OECD countries without national subscriptions, including Canada, Germany and Israel. These countries may be encouraged by our findings to provide free access to their citizens.